AI assistant
Zai Lab Ltd — Director's Dealing 2023
Aug 21, 2023
31208_dirs_2023-08-21_a3b8998f-7738-49bb-9621-d5e4f29fed43.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Zai Lab Ltd (ZLAB)
CIK: 0001704292
Period of Report: 2023-08-14
Reporting Person: Chen Yajing (N/A)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2023-08-14 | Stock Option (Right to Buy) | $25.71 | A | 20000 | Acquired | 2033-08-14 | American Depositary Shares (20000) | Direct |
| 2023-08-14 | Restricted Share Units | $ | A | 5000 | Acquired | American Depositary Shares (5000) | Direct |
Footnotes
F1: Each Stock Option is exercisable for one American Depositary Share (ADS), which represents ten Ordinary Shares of the issuer.
F2: The option vests in equal annual installments over four years beginning on 08/14/2024, the first anniversary of the date of grant.
F3: Each ADS represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs.
F4: Each Restricted Share Unit represents a contingent right to receive one ADS, which represents ten Ordinary Shares of the issuer.
F5: The Restricted Share Units vest in equal annual installments over four years beginning on 08/14/2024, the first anniversary of the date of grant. Vested shares will be delivered to the reporting person following vesting.